Business
Remdesivir study by World Health Organisation casts doubt, disputed by Gilead Sciences Inc – 7NEWS.com.au
The antiviral medication was one of the drugs used to treat US President Donald Trump after his COVID-19 diagnosis.
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug remdesivir does not help patients who have been admitted to hospital.
The American company told Reuters the data appeared inconsistent, the findings were premature and that other studies had validated the drugs benefits.
In a blow to one of the few drugs being used to treat people with COVID-19, the WHO said on Thursday its Solidarity trial had concluded that remdesivir a…
-
Noosa News23 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
General24 hours agoSea search for missing Victorian man off Cape Jaffa ends
-
Noosa News23 hours agoLucky few Zone RV customers rejoice after receiving caravans from collapsed manufacturer
-
General23 hours agoGold, iron ore and population swell big state’s coffers